The use of toads (Bufo regularis) in a new biological assay for screening chemicals or drugs which induce leukaemia in man

M. M. El-Mofty, N. E. Abdel-Meguid, I. A. Sadek, A. E. Essawy, E. A. Abdel-Aleem

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Injection of Egyptian toads Bufo regularis, with adriamycin subcutaneously in the dorsal lymph sac at a dose level of 0.1 mg/toad, once every 3 weeks for 3 months induced pronounced alterations in the blood cells. These alterations were more or less similar to the criteria reported in human leukaemia. These changes were all comparable to those observed after the treatment of the experimental animals with the chemical carcinogen 7,12-dimethylbenz(a)anthracene. It is speculated that toads (Bufo regularis) can be used as biological test animals for screening chemicals or drugs which induce leukaemia in man.

Original languageEnglish
Pages (from-to)657-660
Number of pages4
JournalOncology Reports
Volume4
Issue number3
DOIs
Publication statusPublished - 1997
Externally publishedYes

Keywords

  • 7,12-dimethylbenz(a)anthracine
  • adriamycin
  • Bufo regularis
  • leukaemia

Cite this